Assessment Status | Assessment process complete |
HTA ID | - |
Drug | Insulin Degludec |
Brand | Tresiba® |
Indication | Treatment of diabetes mellitus |
Assessment Process | |
Rapid review commissioned | 17/12/2012 |
Rapid review completed | 04/01/2013 |
Rapid review outcome | Full Pharmacoeconomic Assessment Recommended. |
Full pharmacoeconomic assessment commissioned by HSE | 04/11/2014 |
NCPE assessment completed | 04/05/2015 |
NCPE assessment outcome | Reimbursement Not Recommended at the submitted price. |
December 2015
The HSE has approved reimbursement following confidential price negotiations.